Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese

Journal of the Renin-angiotensin-aldosterone System : JRAAS
Hong-Tao GongFeng-He Du

Abstract

This study aimed to investigate whether mononucleotide polymorphisms of the angiotensinogen gene at promoter were associated with the blood-pressure-lowering response to telmisartan treatment. After a two-week single-blind placebo run-in period, 148 patients with mild-to-moderate primary hypertension received monotherapy with 80 mg/day of telmisartan and then were followed up for eight weeks. The -6A/G and -20A/C polymorphisms of the angiotensinogen gene at promoter were determined through polymerase chain reaction and restriction fragment length polymorphsim analysis. The relationship between these polymorphisms and changes in blood pressure was observed and evaluated after eight weeks of treatment. There were no significant differences between -6A/G, -20A/C polymorphisms of the angiotensinogen gene and blood pressure reductions after treatment, p>0.05. It is suggested that angiotensinogen-6 A/G and angiotensinogen-20 A/C polymorphisms were not associated with the antihypertensive response to telmisartan treatment in Chinese patients with hypertension.

References

Oct 2, 1992·Cell·X JeunemaitreJ M Lalouel
Nov 15, 1989·Analytical Biochemistry·L TilzerR F Moreno
Mar 8, 2003·Hypertension·Maria Teresa SciarroneDaniele Cusi
May 1, 2004·Hypertension·Barry J Materson
Nov 24, 2004·Hypertension·Nina KupperEco J C de Geus
Mar 8, 2007·The Journal of Clinical Hypertension·Alan B Weder
Jan 28, 2010·Expert Opinion on Drug Metabolism & Toxicology·Kim TaverneOlaf Klungel
Jul 18, 2014·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Hyung-Ki KimHak-Jae Kim
May 21, 2015·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Dong-Xing LiuQiang Zhao

❮ Previous
Next ❯

Citations

Aug 28, 2020·Environmental Science and Pollution Research International·Mona M TahaEman M El Tahlawy
Jul 28, 2020·The Journal of Surgical Research·Colton BoudreauMichael Bezuhly

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.